Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cynthion Partners was a New York-based investment firm and global macro thematic hedge fund. Founded in 2006 by John T. Kaden, the firm specialized in macroeconomic investment strategies and traded globally across various asset classes. The firm operated until approximately 2013, after which its leadership transitioned to other investment ventures, including those focused on the technology, media, and emerging legal cannabis sectors. While the firm was not a direct life sciences developer, its principals have since become prominent figures in healthcare and cannabis-related investment and regulatory compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cynthion Partners.